News Detail
Washington, 8 April 2024: One hallmark of the FDA's accelerated approval pathway is the requirement that medicines prove their benefits in confirmatory trials. Now, new research shows that many cancer drugs approved under the pathway couldn't demonstrate survival benefits af......
View Details
Source : Fierce Pharma
U.S. Food and Drug Administration
early approval to drugs
fatal diseases
drug companies
rigorous testing
clinical benefit
confirmatory trials
American Medical Association
American Association for Cancer Research
Health news
Related News
- IIT-BHU developing med device with potential to cure sclerosis (28-11-2024)
- Three widely used BP medicines Combo, five times more effective than current drugs (19-11-2024)
- More than half of patients with rheumatic, musculoskeletal disease use OTC supplements: Study (18-11-2024)
- One-third of older people and individuals admitted to the hospital experienced ADRs: Study (17-11-2024)
- Antithrombotic coating with sheltered positive charges prevents contact activation by controlling factor XII–biointerface binding (13-11-2024)
- IISc scientists develop enzyme-based solution to break antibiotic-resistant biofilms (13-11-2024)
- Japan performs world's first stem cell-treatment to restore vision (12-11-2024)
- Scientist treated her own cancer with viruses she grew in the lab (12-11-2024)
- Innovative use of silk in medical devices (10-11-2024)
- Three-fold throughput nitrosamine analysis in drug products using SIFT-MS (07-11-2024)